This study explores the use of Quantitative Structure-Activity Relationship (QSAR) studies using genetic algorithm (GA) and LightGBM to search for acetylcholinesterase (AChE) inhibitors for Alzheimer's disease. The study uses a dataset of 6,157 AChE inhibitors and their IC₅₀ values. A LightGBM model is trained and evaluated for classification performance. The results show that the LightGBM model achieved high performance on the training and testing set, with an accuracy of 92.49% and 82.47%, respectively. This study demonstrates the potential of GA and LightGBM in the drug discovery process for AChE inhibitors in Alzheimer's disease. The findings contribute to the drug discovery process by providing insights about AChE inhibitors that allow more efficient screening of potential compounds and accelerate the identification of promising candidates for development and therapeutic use.

In this review we hope to explain regarding nanoparticles (NPs), Nanoparticles are very small materials that range from 1 to 100 nm size. And the subclasses of nanoparticles are mentioned. Nanomaterials are formulated by nanoparticles. Research on nanomaterials is used to improve in material technology and synthesis gained the support. Nanomaterials are gradually becoming popularized and starting to arise as commodities. Nanotechnology refers to a set of scientific disciplines and designing where peculiarities that occur at aspects in the nanometre scale are used in the plan, characterization, formulation and use of materials, structures gadgets and system. Here application of nanomaterial and nanotechnology is explained. The use of nanomaterials in the production of biosensors for detection of pathogens, formulation of nanomaterial‐based biosensors for detection of antibiotics, Nanomedicines and the application of nanotechnology in food business Etc were discussed. Hazards and risk of nanomaterials are studied under nanotoxicology. Nanotechnology is ab arising science as would be considered normal to have quick areas of strength for improvements. It is anticipated to contribute altogether to financial development and occupation creation in the next few decades.

The current study was devised to develop alternative, nonantibiotic, and economically viable treatments for bovine mastitis. The concentration of 6.25 μg/mL (25 nm) CuNPs was selected as intramammary (IM) treatment in S. aureus‐induced mastitis in rats as this concentration showed a significant zone of inhibition through the in vitro sensitivity test and minimal cell toxicity on fibroblast cell lines. After, this in vivo study was conducted, and rats were divided into four groups of 6 rats each: group I (healthy control/deionized water), group II (disease control), group III (CuNPs), and group IV (gentamicin). Injection of gentamicin IM for 5 days was selected on the basis of an antibiotic sensitivity test. The therapeutic efficacy of CuNPs was assessed on the basis of clinical signs, mammary gland architecture, bacterial load, oxidative stress parameters, and histopathology of mammary glands. The clinical signs of mastitis in group III ameliorated within 3 days of treatment while in group IV clinical signs ameliorated within 4 days of initiation of treatment. On the 5th day after randomization, bacterial load, mammary gland weights, TOS (Total Oxidant Status), and OSI (oxidative stress index) were significantly lower in the CuNPs group compared to the disease control group and commercial antibiotic group. Similarly, TAS of group III was significantly higher compared to that of groups II and IV indicating that CuNPs have better ameliorative efficacy in mastitis. Treatment with IM, CuNPs @ 6.25 μg/mL showed early recovery, reduced bacterial loads, and amelioration of oxidative stress indices henceforth resulting in marked amelioration in histopathological changes compared to rats in group IV. From this study, it may be concluded that CuNPs may provide a potential alternative therapeutic regimen for the treatment of bovine mastitis.

For the treatment and maintenance of postprandial blood glucose increases (i.e., diabetes mellitus), alpha (α)-amylase is a well-known therapeutic target. In this paper, we report an initial exploration of the work, i.e., in vitro alpha-amylase activity of the hydroalcoholic polyherbal extract of the selected plants. After drying, the plant material is ground individually, and at least 100gm of the crude powder is prepared from each plant. 100gm of each plant was combined, and a total of 500gm of the crude powder (Ichnocarpus frutescens (100 gm)+Ficus dalhousie (100gm)+Crateva magna (100gm)+Alpinia galangal (100gm)+Swertia chirata (100gm)) was prepared to carry out the extraction. This obtained extract was subjected to preliminary phytochemical screening and in vitro alpha-amylase activity. At 16mg/mL, acarbose displayed 78.40±0.36 inhibition, whereas the extract exhibited 72.96±0.70 inhibition, which is significantly comparable. The IC₅₀ value of acarbose was 12.9±1.12, whereas the extract exhibited 13.31±1.12mg/mL. The extract possesses numerous classes of chemicals such as alkaloids, glycosides, tannins, polyphenols, and terpenoids, which can contribute to the antidiabetic activity through alpha-amylase inhibition. This was an initial exploration of the work as a proof of concept for the development of polyherbal tea bag formulation for the treatment of diabetes. In the future, we are aiming to investigate the effectiveness of polyherbal tea bags in the treatment of diabetes using more in vitro and in vivo models. From the present investigation, we have concluded that this extract can be used for the treatment of diabetes.

In the present investigation, Ichnocarpus frutescens, Ficus dalhousiae, Crateva magna, Alpinia galanga, and Swertia chirata plants were selected to formulate polyherbal tea bag. The infusion obtained from these polyherbal tea bags was used to formulate 5 and 10 ointment formulation to perform its wound healing activity. The excision wound model was used to assess the wound healing activity in diabetic as well nondiabetic rats. The mean percentage closure of wound area was calculated on the 3^rd, 6^th, 9^th, 12^th, 15^th, 18^th, and finally 21^st day. The wound healing activity of formulation was found to be significantly compared with that of the reference standard and untreated groups. The percentages of closure of excision wound area on the 21^st day in diabetic animals treated with ointment formulations (F1 and F2) were found to be 93.91±1.65 and 99.12±5.21 respectively, whereas the chloramphenicol sodium drug solution was found to be 99.81±3.16. The percentages of closure of excision wound area in nondiabetic animals treated with ointment formulations (F1 and F2) were found to be 96.81±2.04 and 98.13±1.14, respectively, whereas the chloramphenicol sodium drug solution was found to be 99.15±1.41 at 21^st day. Therefore, from the above results, we have concluded that this polyherbal ointment can be used clinically for the treatment of diabetic and nondiabetic wounds.